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Aim: The aimof this studywas to investigate the impact of gender on the prediction of limited exercise capacity in
heart failure (HF) patients assessed by 6 minute walk test (6-MWT).
Methods: In 147 HF patients (mean age 61 ± 11 years, 50.3% male), a 6-MWT and a Doppler echocardiographic
study were performed in the same day. Conventional cardiac measurements were obtained and global LV
dyssynchrony was indirectly assessed using total isovolumic time − t-IVT [in s/min; calculated as: 60 − (total
ejection time − total ﬁlling time)] and Tei index (t-IVT/ejection time). Patients were divided into two groups
according to gender, which were again divided into two subgroups based on the 6-MWT distance (Group
I: ≤ 300 m, and Group II: N 300 m).
Results: Female patients were younger (p = 0.02), and had higher left ventricular (LV) ejection fraction — EF
(p = 0.007) but with similar 6-MWT distance to male patients (p = 68). Group I male patients had lower
hemoglobin level (p = 0.02) and lower EF (p = 0.03), comparedwith Group II, but none of the clinical or echo-
cardiographic variables differed between groups in female patients. In multivariate analysis, only t-IVT [0.699
(0.552–0.886), p = 0.003], and LV EF [0.908 (0.835–0.987), p = 0.02] in males, and NYHA functional class
[4.439 (2.213–16.24), p = 0.02] in females independently predicted poor 6-MWT distance (b300 m).
Conclusion:Despite similar limited exercise capacity, gender determines the pattern of underlying cardiac distur-
bances; ventricular dysfunction in males and subjective NYHA class in female heart failure patients.© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.1. Introduction
Heart failure (HF) has become a major public health problem [1],
and its incidence, morbidity and mortality are increasing worldwide
[2]. Despite recent advances in medical treatment, patients with per-
sistent symptoms still manifest poor prognosis [3–6]. Many clinical
and echocardiographic parameters have been shown as independent
predictors of these patients [7–11], particularly the six-minute walk
test (6-MWT) which is commonly used to objectively assess patient's
exercise capacity [12–14]. We have previously shown that echocardio-
graphic markers of raised left atrial pressure [15], right ventricular dys-
function [16] and ventricular dyssynchrony [17] correlate with exercise
capacity in HF patients and predict 6-MWT distance results. However,
the impact of gender on limited exercise capacity and its relationshipology, University Clinical Centre
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land Ltd. Open access under CC BY-NCto clinical and echocardiographic predictors of exercise in these patients
have not been evaluated. The aim of this study therefore, was to inves-
tigate the impact of gender in predicting limited exercise capacity,
assessed by 6-MWT, in HF patients.2. Methods
2.1. Study population
We studied 147 patients (mean age 61 ± 11 years, 50.3% male, Table 1) with clinical
diagnosis of congestive HF secondary to ischemic heart disease or non-ischemic etiology,
whowere inNewYorkHeart Association (NYHA) functional classes I–III. Patientswere re-
ferred to the Service of Cardiology, Internal Medicine Clinic, University Clinical Centre of
Kosova, between December 2005 and April 2011. At the time of the study all patients
were on full cardiac medications, optimized at least 2 weeks prior to enrollment, based
on symptoms and renal function: 81% were receiving ACE inhibitors or ARB, 70% beta-
blockers, 11% digoxin, 46% spironolactone, and 64% diuretics. Patients with reduced LV
EF had ischemic etiology in 42%, hypertension in 25%, and unknown etiology in 33%. Pa-
tients with preserved LV EF had ischemic etiology in 44% and hypertension in 56%. All pa-
tients were in sinus rhythm and had symptoms of HF. Patients with clinical evidence of
cardiac decompensation, limited physical activity due to factors other than cardiac symp-
toms (e.g. arthritis), obesity,more thanmild valve regurgitation,more thanmild renal fail-
ure, chronic obstructive pulmonary disease or thosewith recent acute coronary syndrome,
stroke or anemiawere excluded. Patients gave awritten informed consent to participate in
the study, which was approved by the local Ethics Committee.-ND license.
Table 1
Baseline clinical data.
Sex (female, in %) 49.7
Age (years) 61 ± 11
Smoking (%) 31
Diabetes (%) 33
LBBB (%) 25
Body-mass index 28 ± 5
Waist/hip ratio 0.95 ± 0.1
NYHA class 2.3 ± 0.6
Fasting glucose (mmol/L) 7 ± 3.3
Total cholesterol (mmol/L) 4.3 ± 1.3
Triglycerides (mmol/L) 1.7 ± 1
Urea (mmol/L) 9.9 ± 4.5
Creatinine (μmol/L) 109 ± 41
Hemoglobin 128 ± 23
Heart rate (beats/minute) 78 ± 13
Data are mean ± standard deviation. NYHA = New York Heart Association.
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Detailed history and clinical assessment were obtained in all patients, in whom routine
biochemical tests were also performed including hemoglobin, lipid proﬁle, blood glucose
level, and kidney function. Estimated body mass index (BMI) was calculated from weight
and height measurements. Waist and hip measurements were also made and waist/hip
ratio was calculated.
2.3. Echocardiographic examination
A single operator performed all echocardiographic examinations using a Philips Intel-
ligent E-33 systemwith amulti-frequency transducer, and harmonic imaging as appropri-
ate. Imageswere obtainedwith the patient in the left lateral decubitus position and during
quiet expiration according to the recommendations of the American Society of Echocardi-
ography and European Association of Echocardiography [18,19]. End-systolic and end-
diastolic LV dimensions were measured from basal LV M-mode recordings, taken from
the left parasternal long axis view with the M-mode cursor positioned by the tips of the
mitral valve leaﬂets. LV volumes and EF were calculated from the apical 4 and 2 chamber
views using themodiﬁed Simpson's method. Ventricular long axis motion was studied by
placing theM-mode cursor at the lateral and septal angles of themitral ring and the lateral
angle of the tricuspid ring. Total amplitude of long axis motion was measured as
previously described [20] from peak inward to peak outward points. LV and right ventric-
ular (RV) long axis myocardial velocities were also studied using Doppler myocardial im-
aging technique. From the apical 4-chamber view, longitudinal velocities were recorded
with the sample volume placed at the basal part of LV lateral and septal segments as
well as RV free wall. Systolic (S′), as well as early and late (E′ and A′) diastolic myocardial
velocities were measured with the gain optimally adjusted. Mean value of the lateral and
septal LV velocities was calculated. Left atrial diameter was measured from aortic root re-
cordings with the M-mode cursor positioned at the level of the aortic valve leaﬂets.
Diastolic function of the LV and RVwas assessed from their ﬁlling velocities using spectral
pulsed wave Doppler with the sample volume positioned at the tips of the mitral and tri-
cuspid valve leaﬂets, respectively, during a brief apnea. Peak LV andRV early (Ewave), and
late (A wave) diastolic velocities were measured and E/A ratios were calculated. The E/E′
ratiowas calculated from the transmitral Ewave and themean lateral and septal segments
of E′waves. The isovolumic relaxation timewas alsomeasured from aortic valve closure to
mitral valve opening, on the pulsedwaveDoppler recording. LV ﬁlling patternwas consid-
ered ‘restrictive’when E/A ratio was N2.0, E wave deceleration time b140 ms and the left
atrium dilated more than 40 mm in transverse diameter [21].
2.4. Measurements of LV dyssynchrony
Indirect assessment of LV dyssynchrony was obtained by measuring total isovolumic
time (t-IVT), Tei index and LV–RV pre-ejection time delay. Total LV ﬁlling time was mea-
sured from the onset of the E wave to the end of the A wave and ejection time from the
onset to the end of the aortic pulsed Doppler ﬂow velocity. Total isovolumic time (t-IVT)
was calculated as 60 − (total ejection time + total ﬁlling time) and was expressed in s/
min [22]. Tei index was calculated as the ratio between t-IVT and ejection time [22,23].
LV and RV pre-ejection times were measured as the time interval between the onset of
the qwave and the onset of the aortic and pulmonary forward ﬂow velocities, respectively
and the time delay between the two was calculated [24].
Mitral regurgitation severity was assessed by color and continuouswave Doppler and
was graded asmild, moderate, or severe according to the relative jet area to that of the left
atrium as well as the ﬂow velocity proﬁle, in line with the recommendations of the
American Society of Echocardiography [25]. Likewise, tricuspid regurgitation severity
was assessed by color Doppler and continuous-wave Doppler. Retrograde trans-
tricuspid pressure drop N35 mm Hg was taken as an evidence for pulmonary hyperten-
sion [18], after excluding patients with more than mild tricuspid regurgitation. All M-mode and Doppler recordings were made at a fast speed of 100 mm/s with a
superimposed ECG (lead II).
2.5. Six minute walk test
Within 24 h of the echocardiographic examination a 6-MWT was performed on a
level hallway surface and was administered by a specialized nurse blinded to the results
of the echocardiogram. According to the method of Guyatt et al. [26] patients were in-
formed of the purpose and protocol of the 6-MWTwhichwas conducted in a standardized
fashion without interrupting patient's regular medications [27]. A 15 meter ﬂat, obstacle-
free corridorwas used and patientswere instructed towalk as far as they can, turning 180°
after they had reached the end of the corridor, during the allocated time of 6 min. Patients
walked unaccompanied so as not to inﬂuence walking speed. At the end of 6 min the su-
pervising nurse measured the total distance walked by the patient.
3. Statistical analysis
Data are presented as mean ± SD or proportions (% of patients).
Continuous data was compared with two-tailed unpaired Student's t
test and discrete data with Chi-square test. Correlations were tested
with Pearson coefﬁcients. Predictors of 6-MWT distancewere identiﬁed
with univariate analysis and multivariate logistic regression was
performed using the step-wise method, a signiﬁcant difference was
deﬁned as p b 0.05 (2-tailed). Patients were divided according to their
ability to walk N300 m into good (Group I) and limited (Group II) exer-
cise performance groups [28], and were compared using unpaired
Student t-test.
4. Results
4.1. Female vs. male patients (Tables 2 & 3)
Clinical ﬁndings: Female patients were younger (p = 0.02), had
higher BMI (p = 0.04), but lowerwaist/hip ratio (p b 0.001), lower cre-
atinine level (p = 0.02), and lower prevalence of smoking (p b 0.001)
(Table 2). There were no gender related differences in the prevalence
of diabetes, systemic hypertension or LBBB. Females had smaller
aortic root diameter (p b 0.001), smaller left atrium (p = 0.007), LV
EDD and LV ESD dimensions (p b 0.001 for both), and higher LV EF
(p = 0.006) (Table 3). All other clinical and echocardiographic pa-
rameters were not signiﬁcantly different between genders, neither
was 6-MWT distance.
4.2. Female vs. male patients with limited exercise capacity (Tables 4 & 5)
Clinical ﬁndings: Female patients walked longer distance as com-
pared with males in this subgroup with limited exercise capacity
(p = 0.02). They were also younger (p = 0.08), had lower waist/hip
ratio (p b 0.001), lower creatinine level (p = 0.02), and lower preva-
lence of smoking (p b 0.001) (Table 4). The prevalence of diabetes, sys-
temic hypertension and LBBB did not differ between the two genders.
Females had smaller aortic root diameter (p b 0.001), smaller LV EDD
and LV ESD dimensions (p = 0.02 for both), longer Ewave deceleration
time (p = 0.006) and higher septal long axis amplitude (p = 0.03)
(Table 5). All other clinical and echocardiographic parameters were
not signiﬁcantly different between the two subgroups.
4.3. Predictors of limited 6-MWT distance in female patients (Table 6)
None of the biochemical or clinical ﬁndings predicted the limited
6-MWT distance in the univariate analysis. However, in the multivari-
ate analysis, functional NYHA class was the only independent predictor
(p = 0.02) of limited 6-MWT distance in female patients.
4.4. Predictors of limited 6-MWT distance in male patients (Table 7)
In male patients, the univariate analysis showed LV EF (p = 0.007),
isovolumic relaxation time (p = 0.008) and t-IVT (0.04) as predictors
Table 2
Comparison of clinical and biochemical data between patient groups.
Variable Female
(n = 73)
Male
(n = 74)
p value
Age (years) 59 ± 13 63 ± 9 0.02
Smoking (%) 12 50 b0.001
Diabetes (%) 33 38 0.72
Arterial hypertension (%) 66 53 0.15
LBBB (%) 25 16 0.41
Preserved EF (%) 32 19 0.09
Body-mass index 29 ± 5 27 ± 4 0.04
Waist/hip ratio 0.9 ± 0.1 1.0 ± 0.1 b0.001
NYHA class 2.4 ± 0.6 2.3 ± 0.6 0.09
Fasting glucose (mmol/L) 7.3 ± 3.3 7 ± 3.3 0.69
Total cholesterol (mmol/L) 4.5 ± 1.4 4.2 ± 1.1 0.24
Triglycerides (mmol/L) 2.0 ± 1.2 1.5 ± 0.4 0.047
Urea (mmol/L) 9.7 ± 4.6 10 ± 4.2 0.61
Creatinine (μmol/L) 100 ± 39 118 ± 42 0.02
Hemoglobin (gm/dL) 12.5 ± 2.2 13 ± 2.4 0.27
Heart rate (beats/minute) 79 ± 13 77 ± 14 0.51
Six minute walk distance (m) 266 ± 107 268 ± 112 0.91
Data are mean ± standard deviation. NYHA = New York Heart Association.
13G. Bajraktari et al. / IJC Heart & Vessels 1 (2013) 11–16of the limited 6-MWT distance. Total isovolumic time (p = 0.003) and
LV EF (p = 0.02) remained independent predictors of limited 6-MWT
distance, in multivariate analysis, in male patients.Table 3
Comparison of echocardiographic data between patient groups.
Variable Female
(n = 73)
Male
(n = 74)
p value
Systolic LV function
Ejection fraction (%) 42 ± 15 35 ± 13 0.006
Interventricular septum (cm) 1.12 ± 0.2 1.07 ± 0.2 0.238
Left atrium (cm) 4.5 ± 0.7 4.8 ± 0.7 0.007
LV EDD (cm) 5.9 ± 1.1 6.6 ± 1 b0.001
LV ESD (cm) 4.7 ± 1.3 5.5 ± 1.1 b0.001
Septal long axis amplitude (cm) 0.85 ± 0.3 0.87 ± 0.3 0.74
Septal S′ wave (cm/s) 6 ± 2.3 6.3 ± 1.9 0.31
Lateral long axis amplitude (cm) 1.1 ± 0.3 1.1 ± 0.3 0.99
Lateral S′wave (cm/s) 6.2 ± 2.3 6.5 ± 2.6 0.65
LV posterior wall (cm) 1.05 ± 0.4 1.0 ± 0.1 0.19
Aortic root (cm) 3.28 ± 0.3 3.6 ± 0.3 b0.001
Diastolic LV function
A wave velocity (cm/s) 62 ± 25 60 ± 25 0.68
Lateral A′wave (cm/s) 7.8 ± 3.4 7.2 ± 3 0.33
E wave deceleration time (ms) 151 ± 65 157 ± 55 0.53
Lateral E′ wave (cm/s) 6.2 ± 2.3 6.8 ± 3.1 0.19
E/A ratio 1.4 ± 1 1.3 ± 0.9 0.85
Septal A′wave (cm/s) 8 ± 3 8.9 ± 5 0.36
Septal E′ wave (cm/s) 5.4 ± 1.7 6.3 ± 1.8 0.09
E wave velocity (cm/s) 67.5 ± 26 68 ± 26 0.94
LA area 21 ± 10 30 ± 9.7 0.16
Global LV function
t-IVT 13.3 ± 7 12.9 ± 5 0.68
Tei index 0.65 ± 0.4 0.68 ± 0.3 0.71
IVRT 108 ± 32 111 ± 32 0.68
E/E′ ratio 13 ± 8 12 ± 6 0.28
RV function
A wave velocity (cm/s) 51 ± 17 54 ± 20 0.42
E wave deceleration time (ms) 46 ± 12 52 ± 21 0.05
Right long axis amplitude (cm) 2.1 ± 0.5 1.96 ± 0.6 0.29
PSAP (mm Hg) 41 ± 20 46 ± 21 0.31
Right E′wave (cm/s) 8 ± 3 10 ± 4 0.04
Right A′ wave (cm/s) 13 ± 4 15 ± 6 0.31
Right S′wave (cm/s) 11 ± 3 11.3 ± 3 0.68
EDD (cm) 3.2 ± 0.8 3.3 ± 0.9 0.53
LV: left ventricle; RV: right ventricle; A: atrial diastolic velocity; E: early diastolic ﬁlling
velocity; EDD: end-diastolic dimension; ESD: end-systolic dimension; t-IVT: total
isovolumic time; IVRT: isovolumic relaxation time; S′: systolic myocardial velocity, E′:
early diastolic myocardial velocity; A′: late diastolic myocardial velocity.5. Discussion
5.1. Findings
In this study we found that 6-MWT distance was not different be-
tween genders, irrespective of its length, despite the fact that female pa-
tients with stable chronic HF were younger. NYHA class and all cardiac
functional echocardiographic parameters including those of ﬁlling pres-
sures, global dyssynchrony and right ventricular function were not dif-
ferent between males and females. Of note, females had smaller LV and
LA dimensions, and higher LV EF, compared withmales. Predictors of 6-
MWT distance, however, were quite different between the two groups.
Whilemarkers of global LV dyssynchrony, measured by t-IVT, and LV EF
predicted exercise capacity in males, NYHA functional class was the
only predictor of poor 6-MWT in females.
5.2. Data interpretation
In our study, male and female HF patients had equal exercise
capacity, compared to healthy subjects in whom males have better
exercise ability than females [29,30]. Our data show that in this
group of HF patients with limiting exertional symptoms gender differ-
entiates between patients with respect to the underlying mechanisms
for limited exercise capacity, irrespective of the 6 MW distance. Apart
from the slightly raised EF in females, the rest of the cardiac function-
al parameters were not different between genders. Even global mea-
sures of LV dyssynchrony as well as right ventricular structure and
function were all not different between males and females. Strikingly
though, predictors of poor 6-MWT were quite different, while
markers of LV systolic function (EF) and global dyssynchrony (total
isovolumic time) predicted exercise capacity in males, it was only
NYHA class in females that independently predicted poor exercise ca-
pacity. Etiological factors unfortunately, did not help in explaining
such difference between genders, since the prevalence of ischemic
heart disease was similar as well as other co-morbidities, even
NYHA class was not different between groups. Such different mecha-
nistic explanation of exercise intolerance matches what we previously
found in normal exercise, with peak oxygen consumption being de-
termined by stroke volume in males and by raised left atrial pressure
in females [29]. Despite being in HF, our patients followed a similar
pattern with males' exercise capacity determined by ventricularTable 4
Comparison of clinical and biochemical data between patient groupswith limited exercise
capacity (b6 minute walk distance).
Variable Female
(n = 50)
Male
(n = 37)
p value
Age (years) 57 ± 13 63 ± 9 0.008
Smoking (%) 14 49 b0.001
Diabetes (%) 27 40 0.19
Arterial hypertension (%) 64 53 0.36
LBBB (%) 23 17 0.49
Preserved EF (%) 32 19 0.17
Body-mass index 29.5 ± 6 27.5 ± 3 0.08
Waist/hip ratio 0.9 ± 0.1 1.0 ± 0.1 b0.001
NYHA class 2.4 ± 0.6 2.4 ± 0.6 0.91
Fasting glucose (mmol/L) 7 ± 3.4 7.1 ± 3.7 0.88
Total cholesterol (mmol/L) 4.5 ± 1.4 4.2 ± 1.1 0.24
Triglycerides (mmol/L) 2.0 ± 1.2 1.5 ± 0.4 0.047
Urea (mmol/L) 9.4 ± 4.5 11.3 ± 5.3 0.10
Creatinine (μmol/L) 103 ± 46 121 ± 55 0.14
Hemoglobin (gm/dL) 12.7 ± 2.2 13.3 ± 2.4 0.21
Heart rate (beats/minute) 77 ± 15 81 ± 11 0.26
Six minute walk distance (m) 209 ± 66 172 ± 73 0.02
Data are mean ± standard deviation. NYHA = New York Heart Association.
Table 6
Predictors of limited 6 minute walk test in female patients.
Variable Odds ratio (95% CI) p value (b)
Clinical univariate predictors
Hemoglobin 1.005 (0.979–1.031) 0.72
Heart rate 1.031 (0.993–1.070) 0.11
NYHA class 2.228 (0.974–5.100) 0.06
Creatinine 1.008 (0.995–1.022) 0.23
Urea 1.055 (0.945–1.179) 0.34
Body-mass index 1.029 (0.941–1.124) 0.53
Diabetes mellitus 1.224 (0.418–3.590) 0.71
Age 0.995 (0.958–1.034) 0.81
Echocardiographic univariate predictors
t-IVT 0.959 (0.882–1.042) 0.32
Tei index 0.755 (0.230–2.478) 0.64
IVRT 0.987 (0.963–1.011) 0.29
LV EF 0.983 (0.951–1.016) 0.31
E/A ratio 1.435 (0.886–2.325) 0.14
LV EDD 1.063 (0.683–1.066) 0.79
Right long axis amplitude 1.832 (0.885–3.791) 0.11
LV ESD 1.136 (0.770–1.676) 0.52
Left atrium 1.816 (0.855–3.857) 0.12
E wave deceleration time 0.999 (0.991–1.007) 0.76
E/E′ ratio 1.021 (0.959–1.087) 0.51
Lateral long axis amplitude 0.461 (0.080–2.664) 0.39
Septal long axis amplitude 0.436 (0.063–3.001) 0.39
Multivariate predictors
t-IVT 0.961 (0.844–1.095) 0.55
LV ejection fraction 1.002 (0.947–1.061) 0.94
E/A ratio 1.386 (0.686–2.804) 0.36
Hemoglobin 1.017 (0.980–1.054) 0.37
Urea 1.055 (0.915–1.217) 0.46
Age 1.007 (0.946–1.071) 0.83
Body-mass index 1.073 (0.933–1.233) 0.32
Diabetes 1.425 (0.275–7.374) 0.67
NYHA class 4.439 (2.213–16.24) 0.02
LV: left ventricle; A: atrial diastolic velocity; E: early diastolic ﬁlling velocity; EDD: end-
diastolic dimension; ESD: end-systolic dimension; t-IVT: total isovolumic time; IVRT:
isovolumic relaxation time; S′: systolic myocardial velocity, E′: early diastolic myocardial
velocity; A′: late diastolic myocardial velocity.
Table 5
Comparison of echocardiographic data between patient groups with limited exercise
capacity (b6 minute walk distance).
Variable Female
(n = 50)
Male
(n = 37)
p value
Systolic LV function
Ejection fraction (%) 42 ± 15 36 ± 12 0.05
Interventricular septum (cm) 1.11 ± 0.2 1.09 ± 0.2 0.74
Left atrium (cm) 4.5 ± 0.7 4.7 ± 0.6 0.06
LV EDD (cm) 6 ± 1.1 6.5 ± 1 0.02
LV ESD (cm) 4.8 ± 1.2 5.4 ± 1.1 0.02
Septal long axis amplitude (cm) 0.98 ± 0.3 0.78 ± 0.3 0.03
Septal S′ wave (cm/s) 6.8 ± 2.6 7.1 ± 1.1 0.75
Lateral long axis amplitude (cm) 1.2 ± 0.3 1.1 ± 0.4 0.17
Lateral S′wave (cm/s) 6.4 ± 2 6 ± 2 0.34
LV posterior wall (cm) 1.1 ± 0.3 1.0 ± 0.1 0.85
Aortic root (cm) 3.3 ± 0.3 3.6 ± 0.4 b0.001
Diastolic LV function
A wave velocity (cm/s) 61 ± 25 55 ± 22 0.28
Lateral A′wave (cm/s) 7.5 ± 3.7 7.3 ± 3 0.87
E wave deceleration time (ms) 153 ± 71 143 ± 52 0.52
Lateral E′ wave (cm/s) 6.7 ± 2.4 6 ± 2.4 0.22
E/A ratio 1.4 ± 1 1.5 ± 1 0.57
Septal A′wave (cm/s) 9.5 ± 5 7.8 ± 3 0.65
Septal E′ wave (cm/s) 6.1 ± 2.9 6.5 ± 1.8 0.73
E wave velocity (cm/s) 67 ± 22 70 ± 28 0.63
Global LV function
t-IVT 11 ± 6.0 13 ± 5.0 0.71
Tei index 0.7 ± 0.6 0.7 ± 0.3 0.90
IVRT 103 ± 30 111 ± 34 0.43
E/E′ ratio 12.4 ± 5.3 14.7 ± 10 0.24
RV function
E wave velocity (cm/s) 46 ± 11 53 ± 22 0.15
A wave velocity (cm/s) 53 ± 19 52 ± 19 0.89
E wave deceleration time (ms) 183 ± 82 137 ± 58 0.006
Right long axis amplitude (cm) 2.0 ± 0.7 1.9 ± 0.5 0.49
PSAP (mm Hg) 38 ± 20 49 ± 19 0.08
Right E′wave (cm/s) 9 ± 4 9.5 ± 5 0.77
Right A′ wave (cm/s) 13.8 ± 5 14.5 ± 4 0.77
Right S′wave (cm/s) 11 ± 3 11.7 ± 4 0.78
EDD (cm) 3.2 ± 0.5 3.3 ± 1 0.85
LV: left ventricle; RV: right ventricle; A: atrial diastolic velocity; E: early diastolic ﬁlling
velocity; EDD: end-diastolic dimension; ESD: end-systolic dimension; t-IVT: total
isovolumic time; IVRT: isovolumic relaxation time; S′: systolic myocardial velocity, E′:
early diastolic myocardial velocity; A′: late diastolic myocardial velocity.
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breathlessness (which potentially reﬂects left atrial pressure). We
and others [17,31,32] have previously shown that reduced global
systolic function predicts poor 6-MWT through compromised
stroke volume and cardiac output. Likewise dyssynchrony com-
promises the stroke volume entering and ejected by the ventricle
[33,34] which is known to exaggerate with age [35]. Thus, our re-
sults support the previously reported ﬁndings showing signiﬁ-
cant differences in the pattern of exercise intolerance in stable
heart failure patients [32,36-39].5.3. Limitations
We did not have BNP or NT-pro-BNP data in the studied cohort,
which could have helped in better patient stratiﬁcation in terms of se-
verity of ventricular dysfunction and raised wall stress. We however,
relied on our stringent clinical assessment of patients and NYHA
classing. We did not have invasive measurements of left atrial pres-
sures but relied on Doppler measurements, which are known to be
highly reproducible and to closely correlate with invasive pressure
measurements [38].5.4. Clinical implications
In addition to LV EF as the ﬁrst marker of ventricular dysfunction in
heart failure patients, markers of global cavity dyssynchrony (t-IVT)
should be routinely used in assessing patients with exercise intolerance,
particularly males. Until more objective measures of exercise intoler-
ance are available in females, NYHA classing remains the only predictor.
5.5. Conclusions
Despite similar exercise capacity, gender determines the pattern of
underlying cardiac disturbances; ventricular dyssynchrony and LV sys-
tolic dysfunction in males and subjective NYHA class in female heart
failure patients as independent predictors of limited exercise capacity.
Disclosure
None.
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